Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 37Thoracic 7Genitourinary 6Breast 6Gastrointestinal 5Head & Neck 4Sarcoma 2Lymphoid 2CNS 2Other hematologic neoplasm 1Gynecologic 1

Conditions

Gliosarcoma 87Glioblastoma 85Sarcoma 82Central Nervous System Neoplasms 50Dendritic Cell Sarcoma, Interdigitating 33Lymphoma 31Burkitt Lymphoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, Non-Hodgkin 26Lymphoma, Large-Cell, Immunoblastic 26Lymphoma, Large B-Cell, Diffuse 26Leukemia 26Lymphoma, Follicular 24Lymphoma, Mantle-Cell 23Myelodysplastic Syndromes 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell, Marginal Zone 21Leukemia, Myeloid, Chronic-Phase 21Recurrence 20Astrocytoma 20Leukemia, Myeloid, Accelerated Phase 19Hodgkin Disease 19Blast Crisis 18Multiple Myeloma 17Leukemia, Myeloid, Acute 17Glioma 16Rhabdomyosarcoma 15Neoplasms, Plasma Cell 15Liposarcoma 15Brain Neoplasms 14

Interventions

Cyclophosphamide 20pembrolizumab 19Nivolumab 10fludarabine 7Radiosurgery 7Specimen Handling 6Ipilimumab 6Injections 5Celecoxib 5poly ICLC 4Radiation 4Paclitaxel 4Melphalan 4Magnetic Resonance Spectroscopy 4Gemcitabine 4Docetaxel 4Cryosurgery 4durvalumab 3cemiplimab 3Filgrastim 3Etoposide 3Cisplatin 3Blood Specimen Collection 3Biopsy 3trastuzumab deruxtecan 2tislelizumab 2talimogene laherparepvec 2spartalizumab 2fludarabine phosphate 2bempegaldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Radiotherapy × Sarcoma × Clear all
NCT00508443 2026-01-15

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
150 enrolled
BreastDermatologicGastrointestinalLymphoidSarcomaThoracic

Urogenital Diseases, Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Neoplasms, Sarcoma, Spinal Diseases, Spinal Neoplasms

NCT04616248 2026-01-07

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

University of Southern California

Phase 1 Active not recruiting
14 enrolled
BreastDermatologicSarcoma

Bone Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Melanoma, Sarcoma, Osteosarcoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡